IBDEI1PC ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27196,1,3,0)
 ;;=3^Inhalant Induced Maj Neurocog D/O w/ Mod/Sev Use D/O
 ;;^UTILITY(U,$J,358.3,27196,1,4,0)
 ;;=4^F18.27
 ;;^UTILITY(U,$J,358.3,27196,2)
 ;;=^5003401
 ;;^UTILITY(U,$J,358.3,27197,0)
 ;;=F18.97^^110^1313^9
 ;;^UTILITY(U,$J,358.3,27197,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27197,1,3,0)
 ;;=3^Inhalant Induced Maj Neurocog D/O w/o Use D/O
 ;;^UTILITY(U,$J,358.3,27197,1,4,0)
 ;;=4^F18.97
 ;;^UTILITY(U,$J,358.3,27197,2)
 ;;=^5003413
 ;;^UTILITY(U,$J,358.3,27198,0)
 ;;=F18.188^^110^1313^10
 ;;^UTILITY(U,$J,358.3,27198,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27198,1,3,0)
 ;;=3^Inhalant Induced Mild Neurocog D/O w/ Mild Use D/O
 ;;^UTILITY(U,$J,358.3,27198,1,4,0)
 ;;=4^F18.188
 ;;^UTILITY(U,$J,358.3,27198,2)
 ;;=^5003390
 ;;^UTILITY(U,$J,358.3,27199,0)
 ;;=F18.288^^110^1313^11
 ;;^UTILITY(U,$J,358.3,27199,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27199,1,3,0)
 ;;=3^Inhalant Induced Mild Neurocog D/O w/ Mod/Sev Use D/O
 ;;^UTILITY(U,$J,358.3,27199,1,4,0)
 ;;=4^F18.288
 ;;^UTILITY(U,$J,358.3,27199,2)
 ;;=^5003403
 ;;^UTILITY(U,$J,358.3,27200,0)
 ;;=F18.988^^110^1313^12
 ;;^UTILITY(U,$J,358.3,27200,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27200,1,3,0)
 ;;=3^Inhalant Induced Mild Neurocog D/O w/o Use D/O
 ;;^UTILITY(U,$J,358.3,27200,1,4,0)
 ;;=4^F18.988
 ;;^UTILITY(U,$J,358.3,27200,2)
 ;;=^5003415
 ;;^UTILITY(U,$J,358.3,27201,0)
 ;;=F18.159^^110^1313^13
 ;;^UTILITY(U,$J,358.3,27201,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27201,1,3,0)
 ;;=3^Inhalant Induced Psychotic D/O w/ Mild Use D/O
 ;;^UTILITY(U,$J,358.3,27201,1,4,0)
 ;;=4^F18.159
 ;;^UTILITY(U,$J,358.3,27201,2)
 ;;=^5003387
 ;;^UTILITY(U,$J,358.3,27202,0)
 ;;=F18.259^^110^1313^14
 ;;^UTILITY(U,$J,358.3,27202,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27202,1,3,0)
 ;;=3^Inhalant Induced Psychotic D/O w/ Mod/Sev Use D/O
 ;;^UTILITY(U,$J,358.3,27202,1,4,0)
 ;;=4^F18.259
 ;;^UTILITY(U,$J,358.3,27202,2)
 ;;=^5003400
 ;;^UTILITY(U,$J,358.3,27203,0)
 ;;=F18.959^^110^1313^15
 ;;^UTILITY(U,$J,358.3,27203,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27203,1,3,0)
 ;;=3^Inhalant Induced Psychotic D/O w/o Use D/O
 ;;^UTILITY(U,$J,358.3,27203,1,4,0)
 ;;=4^F18.959
 ;;^UTILITY(U,$J,358.3,27203,2)
 ;;=^5003412
 ;;^UTILITY(U,$J,358.3,27204,0)
 ;;=F18.99^^110^1313^22
 ;;^UTILITY(U,$J,358.3,27204,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27204,1,3,0)
 ;;=3^Inhalant Related D/O,Unspec
 ;;^UTILITY(U,$J,358.3,27204,1,4,0)
 ;;=4^F18.99
 ;;^UTILITY(U,$J,358.3,27204,2)
 ;;=^5133360
 ;;^UTILITY(U,$J,358.3,27205,0)
 ;;=F18.21^^110^1313^25
 ;;^UTILITY(U,$J,358.3,27205,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27205,1,3,0)
 ;;=3^Inhalant Use D/O,Mod/Sev,In Remission
 ;;^UTILITY(U,$J,358.3,27205,1,4,0)
 ;;=4^F18.21
 ;;^UTILITY(U,$J,358.3,27205,2)
 ;;=^5003393
 ;;^UTILITY(U,$J,358.3,27206,0)
 ;;=F18.11^^110^1313^24
 ;;^UTILITY(U,$J,358.3,27206,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27206,1,3,0)
 ;;=3^Inhalant Use D/O,Mild,In Remission
 ;;^UTILITY(U,$J,358.3,27206,1,4,0)
 ;;=4^F18.11
 ;;^UTILITY(U,$J,358.3,27206,2)
 ;;=^5151305
 ;;^UTILITY(U,$J,358.3,27207,0)
 ;;=Z00.6^^110^1314^1
 ;;^UTILITY(U,$J,358.3,27207,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27207,1,3,0)
 ;;=3^Exam Control in Clinical Research
 ;;^UTILITY(U,$J,358.3,27207,1,4,0)
 ;;=4^Z00.6
 ;;^UTILITY(U,$J,358.3,27207,2)
 ;;=^5062608
 ;;^UTILITY(U,$J,358.3,27208,0)
 ;;=F45.8^^110^1315^13
